TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17525497

Group type: EXPERIMENTAL
Intervention: Medicinal ointments based on Georgian mineral waters (N1 - 'Achtala'; N2 - 'Sairme'; N3 - 'Tschaltubo'; N4 - 'Amagleba')
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Medicinal ointments based on Georgian mineral waters
Number of subjects: 80
Study: 14699371

Group type: EXPERIMENTAL
Intervention: Medicare
Number of subjects: 631

Group type: EXPERIMENTAL
Intervention: Private Insurance
Number of subjects: 631

Group type: EXPERIMENTAL
Intervention: Medicaid
Number of subjects: 631

Group type: COMPARATOR
Intervention: Geographic Variation
Number of subjects: 631

Group type: COMPARATOR
Intervention: Female Dermatologists
Number of subjects: 631

Group type: COMPARATOR
Intervention: Low Concentration of Dermatologists
Number of subjects: 631
Study: 11826727

Group type: EXPERIMENTAL
Intervention: Grip force control measures in older adults
Number of subjects: 18

Group type: COMPARATOR
Intervention: Grip force control measures in younger adults
Number of subjects: 18
Study: 9505879

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg twice daily
Number of subjects: 222

Group type: COMPARATOR
Intervention: Placebo twice daily
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg twice daily (excluding those who died within 30 days)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Placebo twice daily (excluding those who died within 30 days)
Number of subjects: 222
Study: 8116975

Group type: EXPERIMENTAL
Intervention: Misoprostol (synthetic prostaglandin E1 analog)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Antacid therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cimetidine (control group)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Patients who refused to participate
Number of subjects: 100
Study: 2980288

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (400 mg/day)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 31885287

Group type: EXPERIMENTAL
Intervention: Computer-based multidomain cognitive training program (RehaCom software), 15 weeks, twice a week, 1 hour per session
Number of subjects: 46

Group type: COMPARATOR
Intervention: Standard clinical care (control group)
Number of subjects: 46
Study: 28086201

Group type: EXPERIMENTAL
Intervention: Acute exenatide-infusion
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 26235803

Group type: EXPERIMENTAL
Intervention: eTKVellipsoid
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: eTKVPANK
Number of subjects: 220

Group type: COMPARATOR
Intervention: mTKV
Number of subjects: 220
Study: 23333929

Group type: EXPERIMENTAL
Intervention: Neoadjuvant trans-uterine arterial chemotherapy (TUAC) with paclitaxel (60 mg/m² intravenously on days 1, 8, and 15) and cisplatin (70 mg/m² TUAC) repeated every 3 weeks for 3 cycles.
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Neoadjuvant trans-uterine arterial chemotherapy (TUAC) followed by type III radical hysterectomy (RH).
Number of subjects: 22
Study: 21471415

Group type: EXPERIMENTAL
Intervention: Oxidized zirconium femoral component
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cobalt-chromium femoral component
Number of subjects: 40
Study: 20016113

Group type: EXPERIMENTAL
Intervention: 40% resistance exercise
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: 70% resistance exercise
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: 100% resistance exercise
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: High-intensity exercise
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 68
Study: 16750124

Group type: EXPERIMENTAL
Intervention: Sanitary advice on increasing physical activity during free time
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study: 15243988

Group type: EXPERIMENTAL
Intervention: DikoL program (n = 33)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Standard group (n = 35)
Number of subjects: 106
Study: 10992380

Group type: EXPERIMENTAL
Intervention: Magnetic stimulation of the sacral roots (15 Hz, 50% intensity, 5 seconds per minute for 30 minutes)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Active stimulation
Number of subjects: 75

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 75
Study: 8796406

Group type: EXPERIMENTAL
Intervention: Inhalational nitric oxide (NO) therapy, mean concentration 4.9 +/- 0.8 ppm
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (NO removal)
Number of subjects: 10
Study: 1732342

Group type: EXPERIMENTAL
Intervention: 1.25 mg/kg/day cyclosporine
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: 2.5 mg/kg/day cyclosporine
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: 5 mg/kg/day cyclosporine
Number of subjects: 217
Study: 6433737

Group type: EXPERIMENTAL
Intervention: Neuroleptic technique (NLA) using fentanyl 0.0025 mg/kg and droperidol 0.125 mg/kg (Thalamonal)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Halothane 1%
Number of subjects: 200
Study: 29134517

Group type: EXPERIMENTAL
Intervention: Subcutaneous ketamine 1 mg·kg‐1 (n=30)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Normal saline (placebo group, n=29)
Number of subjects: 59
Study: 28586529

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise (cycling for 30 min at 55% of peak oxygen consumption) on day 1
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise (cycling for 30 min at 55% of peak oxygen consumption) on day 2
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: First exercise session on day 1
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: First exercise session on day 2
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Second exercise session on day 1
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Second exercise session on day 2
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intra-individual difference in change in plasma glucose between testing days after first exercise session
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intra-individual difference in change in plasma glucose between testing days after second exercise session
Number of subjects: 8
Study: 25073879

Group type: EXPERIMENTAL
Intervention: Adalimumab (ADA) + Methotrexate (MTX)
Number of subjects: 779

Group type: COMPARATOR
Intervention: Placebo (PBO) + Methotrexate (MTX)
Number of subjects: 779
Study: 23962543

Group type: EXPERIMENTAL
Intervention: H‐HOPE intervention (twice‐daily infant stimulation using ATVV and four maternal participatory guidance sessions plus two telephone calls)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: H‐HOPE intervention
Number of subjects: 198

Group type: COMPARATOR
Intervention: Control group (attention control)
Number of subjects: 198
Study: 21959024

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) guided treatment
Number of subjects: 319

Group type: COMPARATOR
Intervention: Standard guidelines treatment
Number of subjects: 319
Study: 18460288

Group type: EXPERIMENTAL
Intervention: Cardiovascular MRI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Late gadolinium enhancement and microvascular obstruction imaging
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of gadolinium enhancement, perfusion, and cine imaging
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MRI in clinical trials of heart failure
Number of subjects: 0
Study: 16847470

Group type: EXPERIMENTAL
Intervention: semisynthetic homoharringtonine (ssHHT) at a dose of 5 mg m(‐2) day(‐1) for 9 days
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: semisynthetic homoharringtonine (ssHHT)
Number of subjects: 18
Study: 14671165

Group type: EXPERIMENTAL
Intervention: Alendronate 10 mg daily for 2 years
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 241

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 241
Study: 10071025

Group type: EXPERIMENTAL
Intervention: Surveillance Biopsies (SB)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Clinically Indicated Biopsies (CB)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Overall Biopsy Procedures
Number of subjects: 126
Study: 7747718

Group type: EXPERIMENTAL
Intervention: 14-day infusion of 30 mg/m2 of carboplatin (CBDCA) daily (Group A)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 21-day infusion of carboplatin (CBDCA) beginning from the first day of radiotherapy (Group B)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Both groups received conventional radiotherapy (RT) with total doses ranging from 65 to 70 Gy
Number of subjects: 21
Study: 1675368

Group type: EXPERIMENTAL
Intervention: Insecticide-treated bed nets
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Chemoprophylaxis with maloprim
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 6271844

Group type: EXPERIMENTAL
Intervention: Nabilone
Number of subjects: 80

Group type: COMPARATOR
Intervention: Prochlorperazine
Number of subjects: 80
Study: 31587470

Group type: EXPERIMENTAL
Intervention: Number-based game
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Working memory (WM) game
Number of subjects: 148

Group type: COMPARATOR
Intervention: Control game
Number of subjects: 148
Study: 31131616

Group type: EXPERIMENTAL
Intervention: Probiotic blend containing Lactobacillus acidophilus NCFM (1010 cfu), Lactobacillus paracasei Lpc‐37 (2.5×10^9 cfu), Bifidobacterium animalis subsp. lactis strains Bl‐04 (2.5×10^9 cfu), Bi‐07 (2.5×10^9 cfu), and HN019 (1010 cfu)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo (microcrystalline cellulose)
Number of subjects: 156
Study: 28424260

Group type: EXPERIMENTAL
Intervention: Low-phytate maize (LP; 1.6 mg/g)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control maize (C; 7.1 mg/g)
Number of subjects: 22
Study: 25918111

Group type: EXPERIMENTAL
Intervention: [(11)C]ORM‐13070 during ketamine infusion
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: [(11)C]ORM‐13070 after atomoxetine combined with cold stimulation
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control PET scan with [(11)C]ORM‐13070
Number of subjects: 8
Study: 23496375

Group type: EXPERIMENTAL
Intervention: Itraconazole 400 mg daily for 6 months plus supportive therapy
Number of subjects: 31

Group type: COMPARATOR
Intervention: Supportive treatment alone
Number of subjects: 31
Study: 21124304

Group type: EXPERIMENTAL
Intervention: D-cycloserine (DCS) 1000 mg
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Glycine 0.3 g/kg
Number of subjects: 44
Study: 19952657

Group type: EXPERIMENTAL
Intervention: Direct flow island flap
Number of subjects: 122

Group type: COMPARATOR
Intervention: Reverse flow island flap
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Suturing
Number of subjects: 122
Study: 18089340

Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 15306704

Group type: EXPERIMENTAL
Intervention: Artesunate 4 mg/kg followed by mefloquine 15 mg/kg simultaneously (group A)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Artesunate 4 mg/kg followed by mefloquine 15 mg/kg after 8 hours (group B)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Artesunate 4 mg/kg followed by mefloquine 15 mg/kg after 24 hours (group C)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 360
Study: 11428736

Group type: EXPERIMENTAL
Intervention: Olopatadine 0.1% ophthalmic solution twice daily adjunctive to loratadine 10 mg once daily
Number of subjects: 94

Group type: COMPARATOR
Intervention: Loratadine 10 mg once daily
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Olopatadine 0.1% ophthalmic solution plus loratadine 10 mg
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Olopatadine plus loratadine
Number of subjects: 94
Study: 9600500

Group type: EXPERIMENTAL
Intervention: Topical nasal corticosteroids
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 9037279

Group type: EXPERIMENTAL
Intervention: 60 million units of interferon alpha-2b, instilled weekly for 12 weeks followed by once-monthly instillation for 1 year
Number of subjects: 90

Group type: COMPARATOR
Intervention: Double-distilled water, used as control
Number of subjects: 90
Study: 1773908

Group type: EXPERIMENTAL
Intervention: Dimethindene maleate 3 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dimethindene maleate 6 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Chlorpheniramine maleate 12 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 7128568

Group type: EXPERIMENTAL
Intervention: Treadmill test at various times of day
Number of subjects: 31
Study: 31603205

Group type: EXPERIMENTAL
Intervention: SQ-LNSs until 6 mo postpartum, and SQ-LNSs for offspring (6 mg Fe/d) from 6 to 18 mo of age
Number of subjects: 1320

Group type: COMPARATOR
Intervention: Multiple micronutrient supplements until 6 mo postpartum
Number of subjects: 1320

Group type: COMPARATOR
Intervention: Iron and folic acid until delivery
Number of subjects: 1320

Group type: EXPERIMENTAL
Intervention: LNS group (SQ-LNSs)
Number of subjects: 1320

Group type: COMPARATOR
Intervention: Non-LNS group
Number of subjects: 1320
Study: 31450014

Group type: EXPERIMENTAL
Intervention: Walking pace of 2-2.9 mph
Number of subjects: 21919

Group type: EXPERIMENTAL
Intervention: Walking pace of 3-3.9 mph
Number of subjects: 21919

Group type: EXPERIMENTAL
Intervention: Walking pace of ≥4 mph
Number of subjects: 21919
Study: 28065635

Group type: EXPERIMENTAL
Intervention: Home-delivered meals and nutrition education for 10 days
Number of subjects: 21

Group type: COMPARATOR
Intervention: Usual care and nutrition education
Number of subjects: 21
Study: 23922290

Group type: EXPERIMENTAL
Intervention: Nurse-led 6-month comprehensive pulmonary rehabilitation program
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional education (Control)
Number of subjects: 30
Study: 24244703

Group type: EXPERIMENTAL
Intervention: Swedish Björknäs intervention (lifestyle intervention)
Number of subjects: 0
Study: 21177724

Group type: EXPERIMENTAL
Intervention: PMEA-coated cardiopulmonary bypass circuits
Number of subjects: 30

Group type: COMPARATOR
Intervention: Phisio-coated cardiopulmonary bypass circuits
Number of subjects: 30
Study: 18817894

Group type: EXPERIMENTAL
Intervention: Pantescal (Bionap, Italy)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 17138781

Group type: EXPERIMENTAL
Intervention: Home visit triage (n=728)
Number of subjects: 1459

Group type: COMPARATOR
Intervention: Telephone triage (n=731)
Number of subjects: 1459
Study: 14561987

Group type: EXPERIMENTAL
Intervention: PBSC (filgrastim‐mobilized peripheral blood stem cell) donation
Number of subjects: 329

Group type: COMPARATOR
Intervention: BM (bone marrow) donation
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: PBSC donation
Number of subjects: 329

Group type: COMPARATOR
Intervention: BM donation
Number of subjects: 329
Study: 11121633

Group type: EXPERIMENTAL
Intervention: Arm A: 64 Gy RT + BCNU (80 mg/m2, days 1-3, 56-58, then 4 cycles every 8 weeks)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Arm B: 70.4 Gy RT + BCNU (80 mg/m2, days 1-3, 56-58, then 4 cycles every 8 weeks)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Arm A: 64 Gy RT + BCNU
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Arm B: 70.4 Gy RT + BCNU
Number of subjects: 104
Study: 8935450

Group type: EXPERIMENTAL
Intervention: Intensive individual anti-smoking advice given in parallel with hospital antenatal care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 1874201

Group type: EXPERIMENTAL
Intervention: Stimulation of ear and paravertebral points with small doses of fentanyl (mean 1.2 micrograms kg‐1)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Moderate-dose fentanyl (mean 22.9 micrograms kg‐1)
Number of subjects: 29
Study: 6863224

Group type: EXPERIMENTAL
Intervention: amoxapine (260 mg daily for 4 weeks)
Number of subjects: 142

Group type: COMPARATOR
Intervention: doxepin (130 mg daily for 4 weeks)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: amoxapine
Number of subjects: 142

Group type: COMPARATOR
Intervention: doxepin
Number of subjects: 142
Study: 31385755

Group type: EXPERIMENTAL
Intervention: Radiomics-based machine learning model
Number of subjects: 21

Group type: COMPARATOR
Intervention: Visual assessment
Number of subjects: 21

Group type: COMPARATOR
Intervention: Area of low attenuation
Number of subjects: 21

Group type: COMPARATOR
Intervention: Average Hounsfield unit
Number of subjects: 21
Study: 28275998

Group type: EXPERIMENTAL
Intervention: Factors related to access to care
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Insurance acceptance
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Online information about what other parents think of a practice
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Physicians' interpersonal skills and pediatrician-specific traits
Number of subjects: 367
Study: 26915823

Group type: EXPERIMENTAL
Intervention: Diesel exhaust (DE) exposure (300 μg PM2.5/m(3) for 120 min)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Filtered air (FA) exposure
Number of subjects: 27
Study: 24875032

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Epsilon-aminocaproic acid
Number of subjects: 125

Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 125
Study: 22939642

Group type: EXPERIMENTAL
Intervention: Low-molecular weight hyaluronic acid (HA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Medium-molecular weight hyaluronic acid (HA)
Number of subjects: 40
Study: 19107596

Group type: EXPERIMENTAL
Intervention: Pneumatic dilation
Number of subjects: 761

Group type: COMPARATOR
Intervention: Laparoscopic myotomy
Number of subjects: 761
Study: 17460334

Group type: EXPERIMENTAL
Intervention: Creatine (Cr)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Creatine (Cr) with Glycerol (Gly)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (Pl)
Number of subjects: 24
Study: 14691424

Group type: EXPERIMENTAL
Intervention: Eptifibatide
Number of subjects: 861

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 861
Study: 11777361

Group type: EXPERIMENTAL
Intervention: Patients aged 70 years or older
Number of subjects: 902

Group type: COMPARATOR
Intervention: Patients younger than 70 years
Number of subjects: 902

Group type: EXPERIMENTAL
Intervention: Older patients after passing a spontaneous breathing trial
Number of subjects: 902

Group type: EXPERIMENTAL
Intervention: Age of 70 years or older
Number of subjects: 902
Study: 9821527

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Citrate
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Polygeline
Number of subjects: 30
Study: 7821201

Group type: EXPERIMENTAL
Intervention: Endoscopic treatment with tissue-preserving substances (epinephrine +/- NaCl in 36%, fibrin glue +/- epinephrine in 24%)
Number of subjects: 1139

Group type: EXPERIMENTAL
Intervention: Endoscopic treatment with tissue-damaging procedures (epinephrine + polidocanol +/- NaCl in 26%, epinephrine + thermocoagulation in 7%)
Number of subjects: 1139

Group type: EXPERIMENTAL
Intervention: Conservative treatment after recurrent bleeding
Number of subjects: 1139

Group type: EXPERIMENTAL
Intervention: Operative treatment after recurrent bleeding
Number of subjects: 1139

Group type: EXPERIMENTAL
Intervention: Patients in high risk group (older than 60 years; high amount of bleeding)
Number of subjects: 1139

Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 1139

Group type: EXPERIMENTAL
Intervention: Age of patient
Number of subjects: 1139

Group type: EXPERIMENTAL
Intervention: Haemoglobin < 8 g/dl on admission
Number of subjects: 1139

Group type: EXPERIMENTAL
Intervention: Initial severity of bleeding (Forrest group I)
Number of subjects: 1139

Group type: EXPERIMENTAL
Intervention: Recurrence of bleeding
Number of subjects: 1139
Study: 2480926

Group type: EXPERIMENTAL
Intervention: Bipolar tumor probe
Number of subjects: 30

Group type: COMPARATOR
Intervention: Prosthetic tube
Number of subjects: 30
Study: 4416359

Group type: EXPERIMENTAL
Intervention: Selective shunt
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-selective or total shunt
Number of subjects: 0
Study: 31743896

Group type: EXPERIMENTAL
Intervention: Group 1 (physicians received baseline survey results)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Group 2 (physicians did not receive baseline survey results)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Group 1
Number of subjects: 53
Study: 30576507

Group type: EXPERIMENTAL
Intervention: Neonatal vitamin A supplementation (NVAS)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 181
Study: 28359325

Group type: EXPERIMENTAL
Intervention: BCG vaccination at birth
Number of subjects: 2200

Group type: COMPARATOR
Intervention: BCG vaccination at 14 weeks of age
Number of subjects: 2200
Study: 26163828

Group type: EXPERIMENTAL
Intervention: Short-term psychodynamic psychotherapy (STPP)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 106
Study: 23649554

Group type: EXPERIMENTAL
Intervention: rhPTH(1-84) 100 µg/d
Number of subjects: 38
Study: 21353211

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided lidocaine injection (group U/S)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard infiltration by manual palpation (group M)
Number of subjects: 200
Study: 19691829

Group type: EXPERIMENTAL
Intervention: 7 days of ciprofloxacin or 7 days of empirical beta-lactams +/− gentamicin intravenously with early switch to oral ciprofloxacin followed by 7 days of blinded placebo
Number of subjects: 400

Group type: COMPARATOR
Intervention: 7 days of ciprofloxacin or 7 days of empirical beta-lactams +/− gentamicin intravenously with early switch to oral ciprofloxacin followed by 7 days of blinded ciprofloxacin
Number of subjects: 400
Study: 16467702

Group type: EXPERIMENTAL
Intervention: 150 mg roxithromycin daily for 3 months
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 12718812

Group type: EXPERIMENTAL
Intervention: Intervention schools (community participation, peer education, public lectures, health clubs, training of STD treatment providers)
Number of subjects: 3754

Group type: EXPERIMENTAL
Intervention: Intervention schools
Number of subjects: 3754

Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 3754